• No results found

Design and development of polynuclear ruthenium and platinum polypyridyl complexes in search of new anticancer agents

N/A
N/A
Protected

Academic year: 2021

Share "Design and development of polynuclear ruthenium and platinum polypyridyl complexes in search of new anticancer agents"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Design and development of polynuclear ruthenium and platinum

polypyridyl complexes in search of new anticancer agents

Schilden, Karlijn van der

Citation

Schilden, K. van der. (2006, January 26). Design and development of polynuclear

ruthenium and platinum polypyridyl complexes in search of new anticancer agents.

Retrieved from https://hdl.handle.net/1887/4377

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4377

(2)

Design and Development of

Polynuclear Ruthenium and Platinum

Polypyridyl Complexes

in Search of New Anticancer Agents

PROEFSCHRIFT

ter verkrij

ging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van Rector M agnificus Dr.

D.

D.

Breimer,

hoogleraar in de faculteit der W iskunde

en Natuurwetenschappen en die der Geneeskunde,

volgens besluit van het College voor Promoties

te verdedigen op donderdag 26 j

anuari 2006

klokke 15.

15 uur

door

(3)

Promotiecommissie

Promotor : Prof. Dr. J. Reedijk

Co-promotor : Dr. J. G. Haasnoot

Referent : Prof. Dr. E. Alessio (Università di Trieste)

Overige leden : Prof. Dr. J. Brouwer Prof. Dr. H. S. Overkleeft

Prof. Dr. G. Sava (Università di Trieste) Dr. M . Ubbink

The research described in this thesis was financially supported by the Council for Chemical Sciences of the Netherlands Organization for Scientific Research (CW -NW O). Financial support of COST Chemistry D20 for the stay in Brno is gratefully acknowledged.

Cover: Picture of the crystal structure of the dinuclear complex [(tpy)Ru(dtdeg)PtCl]3+ and microscopic image of cisplatin-sensitive human ovarian carcinoma cells after three days of incubation with 20 µM of the tetranuclear complex [Cl3Ru(dtdeg)Ru(dtdeg)Ru(dtdeg)RuCl3]Cl4.

(4)
(5)

Table of contents

List of abbreviations 6

Chapter 1 9

General introduction

Chapter 2 47

A paramagnetic dinuclear ruthenium(II)-ruthenium(III) complex: synthesis and strategy for 1H NM R studies

Chapter 3 65

Dinuclear ruthenium(II) complexes with long and flexible linkers: rotational behavior of coordinated 9-ethylguanine and biological properties

Chapter 4 87

Heterodinuclear ruthenium-platinum complexes with long and flexible linkers: crystal structure and cytotoxicity

Chapter 5 109

Trinuclear and tetranuclear ruthenium and platinum complexes with long and flexible linkers: syntheses, characterization and biological properties

Chapter 6 133

(6)

Chapter 7 151 Summary, general discussion and future prospects

Samenvatting 159

Ontwerp en ontwikkeling van polynucleaire rutheniumcomplexen en ruthenium-platinacomplexen

Op zoek naar nieuwe medicijnen tegen kanker

Curriculum vitae 163

List of Publications 164

(7)

6

List of abbreviations

A2780cis cisplatin-sensitive human ovarian carcinoma cellline A2780R cisplatin-resistanthuman ovarian carcinoma cellline A549 lung cancer cellline

bpy 2,2’-bipyridine cod cyclooctadiene

COSY Correlation Spectroscopy

d doublet

DM F dimethylformamide DM SO dimethylsulfoxide DNA deoxyribonucleic acid

dtdeg bis[4’-(2,2’:6’,2”-terpyridyl)]-diethyleneglycolether H4edta ethylene diamine tetraacetic acid

en ethylene diamine

EPR electron paramagnetic resonance spectroscopy ESI-M S electrospray ionization mass spectroscopy EtOH ethanol

9egua 9-ethylguanine

FAAS flameless atomic absorption spectroscopy FBS fetalbovine serum

GSH glutathione

HBL-100 non tumorigenic epithelialcellline HCT-15 colorectalcancer cellline

hr hour

Hs683 glioblastoma cellline

IC50 concentration of a compound thatinduces 50 % of growth inhibition of

cells compared to untreated cells J couplin constantin NM R

(8)

7

L1210/0 cisplatin-sensitive mouse leukemia cell line L1210/2 cisplatin-resistant mouse leukemia cell line LoVo colorectal cancer cell line

M molar

MCF-7 breast cancer cell line MeOH methanol

MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide m/z mass to charge ratio

NMR nuclear magnetic resonance NOE nuclear Overhauser effect

NOESY nuclear Overhauser effect spectroscopy OD optical density

PBS phosphate buffered saline ppm parts per million

q quartet

qpy 4’-pyridyl-2,2’:6’,2”-terpyridine RT room temperature

s singlet, or second

SAR structure-activity relationships

t triplet

T1 nuclear longitudinal relaxation time

T2 nuclear transverse relaxation time

(9)

Referenties

GERELATEERDE DOCUMENTEN

Omdat het in dit proefschrift gepresenteerde onderzoek zich heeft gericht op de synthese en evaluatie van polynucleaire rutheniumcomplexen en polynucleaire

Design and development of polynuclear ruthenium and platinum polypyridyl complexes in search of new anticancer agents.. Schilden, Karlijn

Parting from the observation that the complex RAPTA-T displayed a similar in vivo activity to NAMI-A, albeit with lower systemic toxicity, a group of derivatives from this parent

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Ammine-chlorido derivatives 27 Dimethylsulfoxide complexes 27 Complexes with other heterocyclic ligands 29 Ruthenium polyaminocarboxylate complexes 31

The groups of Chikuma and Reedijk synthesised dinuclear platinum(II) complexes (see Fig.1.9) that display much higher in vitro cytotoxicity than cisplatin on several human

The only remarkable difference is the presence of a broad, weak peak at 3000-3500 cm -1 in the spectrum of 1b, which appears not only as a consequence of the aqua ligand, but also

At high temperatures, the 9-ethylguanine moiety is rotating fast at the NMR time scale, while at low temperatures, this model base shows a preferred orientation, with the keto group